ArticleCureus2026
Primary Spinal Marginal Zone Lymphoma Presenting With Spinal Cord Compression: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extranodal marginal zone lymphoma (EMZL) is an indolent B-cell lymphoma that typically arises in mucosal or extranodal tissues. Spinal involvement is exceptionally rare and may present with spinal cord compression, posing diagnostic and therapeutic challenges. We report the case of a 70-year-old man who presented with progressive paraparesis following a four-month history of lumbosciatic pain. MRI revealed an epidural and paravertebral mass extending from L2 to L4 with vertebral body destruction and spinal canal invasion. Urgent decompressive laminectomy with subtotal resection was performed. Histopathology and immunohistochemistry confirmed EMZL. Staging excluded systemic disease. The patient received adjuvant radiotherapy (24 Gy in 12 fractions) using volumetric modulated arc therapy (VMAT). Treatment was well tolerated, with neurological recovery and a good clinical outcome. Spinal EMZL is a rare cause of spinal compression. Accurate diagnosis requires integrated histopathologic and immunophenotypic evaluation. Combined surgical decompression and standard-dose radiotherapy can provide effective local control and favorable outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.